Disparities Identified in Telemedicine Use for Neurologic Conditions
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Nov. 20, 2024 -- Disparities exist in telemedicine utilization for neurologic conditions, according to a study published online Nov. 20 in Neurology: Clinical Practice.
Marisa Patryce McGinley, D.O., from the Cleveland Clinic, and colleagues characterized outpatient telemedicine utilization for neurologic conditions and identified potential disparities at an academic medical health care system. Patients completing in-person visits were compared to those completing telemedicine visits. Telemedicine utilization was compared prepandemic (before March 2020), early pandemic (March to June 2020), and late pandemic (July 2020 to July 2022).
During the study time frame, 242,273 patients completed 752,174 visits. The researchers found that telemedicine utilization differed significantly between time frames, with the highest utilization early in the pandemic. The odds of a telemedicine visit were significantly lower for individuals who were older (odds ratio, 0.97), were Black or Hispanic (odds ratios, 0.84 and 0.70, respectively), had a higher Area Deprivation Index (odds ratios, 0.85, 0.80, 0.78, and 0.65 for 20 to 40, 40 to 60, 60 to 80, and ≥80 percent, respectively), had nonprivate insurance (odds ratios, 0.78, 0.84, and 0.60 for Medicaid, Medicare, and self-pay, respectively), and had non-English preferred language (odds ratio, 0.61) in the late pandemic time frame. Significantly higher odds of a telemedicine visit were seen for individuals who were female (odds ratio, 1.25) and lived outside of the greater Cleveland area (odds ratios, 2.33 and 3.32 for other Ohio and out of state, respectively). No difference was seen for visits completed by rural patients versus metropolitan patients.
"Telemedicine has the potential to improve access to neurologic care and the disparities in utilization identified in this study may aid researchers and institutions in creating strategies to ensure equitable implementation," the authors write.
Several authors disclosed ties to biopharmaceutical companies, including Genentech, which partially funded the study.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted November 2024
Read this next
Mental Health, Neurodevelopmental Diagnoses in Publicly Insured Children on the Rise
WEDNESDAY, April 30, 2025 -- The percentage of publicly insured children receiving any mental health or neurodevelopmental disorder diagnosis significantly increased between 2010...
American Academy of Neurology, April 5-9
The annual meeting of the American Academy of Neurology was held this year from April 5 to 9 in San Diego. Participants included clinicians, academicians, allied health...
Use of Parallel Transmit 7T MRI Changes Management for Epilepsy Surgery
THURSDAY, March 27, 2025 -- Parallel transmit (pTx) 7 Tesla (T) magnetic resonance imaging (MRI) changes management in more than half of adult candidates for epilepsy surgery...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.